Eric is a commercial and market access leader with over 30 years of experience in the Life Sciences industry, specializing in go-to-market strategies, commercial analytics, and commercial operations functions. He serves as a valued advisor to global pharmaceutical companies as well as biotech and health tech startups. Eric has a successful track record of establishing and leading the commercial business units at Decision Resources Group (DRG), Artisan Healthcare Consulting, and Trinity Life Sciences. These experiences helped him to build depth across many disciplines, including pricing, reimbursement, local market analytics, health systems/IDNs, pull-through systems and strategies. He is well versed in several therapeutic areas such as immunology, CNS/mental health, cardiovascular, metabolism, oncology, respiratory, and several rare diseases.

Eric began his career with G.D. Searle, advancing through several sales leadership and operational roles before leading the commercial analytics function at Biogen.  He received his BSBA from Fordham University and his MBA from the Olin Graduate School of Business.